Trusted Blood, Saving Balochistan
Call : +92 301 344 6276
Working Hours : Mon-Saturday, 08am - 09pm
Why Choose Us

Leading Blood Safety & Transfusion Regulation in Balochistan

01. What does you do?

1. Licensing and Registration.
​The BBTA is responsible for the formal registration and licensing of all public and private blood banks operating within Balochistan. No facility can legally function without meeting the authority's strict safety and technical criteria.

​2. Standardized Inspections.
​To maintain high medical standards, the authority conducts regular inspections of blood centers. These evaluations focus on:
​Storage Facilities: Ensuring blood is stored at the correct temperatures.
​Equipment Calibration: Verifying that laboratory machinery is functioning accurately.
​SOP Compliance: Checking that staff follow Standard Operating Procedures for hygiene and safety.

​3. Mandatory Screening Oversight
​One of the most critical services is ensuring that every unit of donated blood is screened for Transfusion Transmissible Infections (TTIs). This includes mandatory testing for:
​Hepatitis B & C, HIV/AIDS, Malaria and Syphilis.

​4. Public Awareness and Advocacy.
​The BBTA actively promotes Voluntary Non-Remunerated Blood Donation (VNRBD). By organizing seminars and collaborating with various sectors (such as law enforcement and educational institutions), they work to build a sustainable and safe blood supply for patients with Thalassemia, Cancer, and emergency trauma.

​5. Technical Training and Support
​The authority provides technical guidelines and training workshops for healthcare professionals and laboratory technicians. This ensures that the workforce is updated on the latest transfusion technologies and best practices in hematology.

​6. Data Collection and Monitoring.
​The BBTA maintains a centralized monitoring system to keep track of blood supply levels, donor records, and the overall performance of blood centers across the province to ensure accountability and transparency.

Thalassemia management and prevention.

Patient Treatment & Management:
Ensuring that Thalassemia patients receive safe, filtered, and screened blood transfusions. This involves coordinating with Regional Blood Centers (RBCs) to provide "Leukocyte-depleted" blood to minimize transfusion reactions.

​Comprehensive Screening:
Conducting mandatory screening of all donated blood units for Thalassemia patients to prevent the transmission of infections like Hepatitis and HIV. Additionally, performing carrier screening for family members of affected patients.

​Clinical Consultation & Examination:
Facilitating clinical check-ups through specialized consultants and hematologists to monitor iron overload, hemoglobin levels, and overall patient health.

​CVS (Chorionic Villus Sampling) Testing:
Supervising and facilitating prenatal diagnostic facilities, specifically the CVS test, which allows for the early detection of Thalassemia in the fetus during pregnancy (usually between 10-13 weeks).

​Centralized Patient Registration:
Maintaining a formal registry of Thalassemia patients across Balochistan to ensure they have consistent access to blood units and medical supplies.

​Data Collection & Research:
Systematically collecting data on the prevalence of Thalassemia in different districts. This data is used for provincial health planning and to identify "hotspot" areas requiring urgent intervention.

​Educational Institution Screening Campaigns:
Organizing mobile screening camps in Schools, Colleges, Universities, and Madrasas. The goal is to identify silent carriers among the youth and provide them with "Thalassemia Carrier Cards."

​Surgical & Related Medical Operations:
Providing oversight for necessary surgical interventions related to Thalassemia complications, such as Splenectomies (removal of the spleen) or gallbladder surgeries, ensuring these procedures are done under strict safety protocols.

​Pre-Marital Screening Advocacy:
Implementing the provincial policy for mandatory blood screening before marriage to prevent the birth of new Thalassemia Major cases.

Patients served each 6 months
0 +